Womens compliance with current folic acid recommendations and achievement of optimal vitamin status for preventing neural tube defects

Human Reproduction

Volumn 26, Issue 6, 2011, Pages 1530-1536

  McNulty, Breige ^a   Pentieva, Kristina ^a   Marshall, Barry ^b   Ward, Mary ^a   Molloy, Anne M ^c   Scott, John M ^c   McNulty, Helene ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b NORTHERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

folate; folic acid intake recommendations; maternal compliance; neural tube defect prevention; vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; VITAMIN B GROUP;

ADULT; ARTICLE; CONCEPTION; CONTROLLED STUDY; CYANOCOBALAMIN BLOOD LEVEL; FEMALE; FIRST TRIMESTER PREGNANCY; FOLIC ACID BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MATERNAL CARE; NEURAL TUBE DEFECT; PATIENT COMPLIANCE; PREGNANT WOMAN; PRENATAL CARE; RELIABILITY; TIME PERCEPTION; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; BLOOD; DIET SUPPLEMENTATION; PREGNANCY;

ADULT; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HUMANS; NEURAL TUBE DEFECTS; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL CARE; VITAMIN B 12;

EID: 79957511968     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der078     Document Type: Article

References (34)

1. Andersson A, Hultberg B, Brattstrom L, Isaksson A. Decreased serum homocysteine in pregnancy. Clin Chem Lab Med 1992;30:377-379.
2. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, Botting B, Cocchi G, de Vigan C, de Walle H et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: Are the recommendations working. Br Med J 2005;330:571-573. (Pubitemid 40380351)
3. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morb Mortal Wkly Rep 1992;41:1-8.
4. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA et al. Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. J Am Med Assoc 2007;297:2351-2359. (Pubitemid 46883748)
5. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-1835. (Pubitemid 23003073)
6. Daly LE, Kirke PN, Molloy AM, Weir DC, Scott JM. Folate levels and Neural tube defects. Implications for prevention. J Am Med Assoc 1995;274:1698-1702.
7. Department of Health. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. London: The Stationary Office, 1991,41.
8. Department of Health. Folic Acid and the Prevention of Neural Tube Defect: Report from an Expert Advisory Group. Heywood: DOH Health Publication Unit, 1992,21.
9. Department of Health. Folic Acid and the Prevention of Disease. Report on Health and Social Subjects. Heywood: DOH Health Publication Unit, 2002,50.
10. De Wals P, Tairou F, Van Allen MI, Uh Sh, Lowry RB, Sibbald B, Evans JA, Van den Hof MC, Zimmer P, Crowley M et al. Reduction in Neural-Tube defects after folic acid fortification in Canada. N Engl J Med 2007;357:135-142. (Pubitemid 47057731)
11. DSS Research. Available at: Http://www.dssresearch.com/toolkit/sscalc/ size-a2.asp (October 2010, date last accessed).
12. Hertrampf E, Cortés F. National food-fortification program with folic acid in Chile. Food Nutr Bull 2008;29:S231-S237.
13. Holmes VA,Wallace JM, Alexander HD, Gilmore WS, Bradbury I,Ward M, Scott JM, McFaul P, McNulty H. Homocysteine is lower in the third trimester of pregnancy in women with enhanced folate status from continued folic acid supplementation. Clin Chem 2005;51:629-634. (Pubitemid 40300240)
14. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. J Am Med Assoc 2001;285:2981-2986. (Pubitemid 32550116)
15. Inskip HM, Crozier SR, Godfrey KM, Borland SE, Cooper C, Robinson SM, Southampton Women's Survey Study Group. Women's compliance with nutrition and lifestyle recommendations before pregnancy: General population cohort study. Br Med J 2009;338:481-486.
16. Kelleher BP, Broin SDO. Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol 1991;44:592-595.
17. Koren A, Mawn B. The context of unintended pregnancy among married women in the USA. J Fam Plann Reprod Health Care 2010;36:150-158.
18. Leino A. Fully automated measurement of total homocysteine in plasma and serum on the Abbott IMx analyzer. Clin Chem 1999;45:569-571. (Pubitemid 29165970)
19. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995;345:149-151.
20. Molloy AM, Scott JM. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol 1997;281:43-53. (Pubitemid 27362441)
21. Molloy AM, Kirke PN, Troendle JF, Burke H, Brody LC, Scott JM, Mills JL. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defects and no folic acid supplementation. Pediatrics 2009;123:917-923.
22. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Council Vitamin Study. Lancet 1991; 338:131-137.
23. Murphy MM, Molloy AM, Ueland P, Fernandez-Ballart JD, Schneede J, Arija V, Scott JM. Longitudinal study of the effect of pregnancy on maternal and fetal cobalamin status in healthy women and their offspring. J Nutr 2007;137:1863-1867. (Pubitemid 47292731)
24. Nilsen RM, Vollset SE, Gjessing HK, Magnus P, Meltzer HM, Haugen M, Ueland PM. Patterns and predictors of folic acid supplement use among pregnant women: The Norwegian Mother and Child Cohort Study. Am J Clin Nutr 2006;84:1134-1141. (Pubitemid 44730385)
25. Ray JG, Singh G, Burrows RF. Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG 2004; 111:399-408. (Pubitemid 38621868)
26. Ray JG, Wyatt PR, Thompson MD, Vermeulen MJ, Meier C, Wong PY, Farrell SA, Cole DE. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology 2007;18:362-366. (Pubitemid 46624947)
27. Rocca CH, Krishnan S, Barrett G, Wilson M. Measuring pregnancy planning: An assessment of the London Measure of Unplanned Pregnancy among urban, south Indian women. Demogr Res 2010; 23:293-334.
28. Savage DG, Lindenbaum J. Folate-cobalamin interactions. In Bailey LB (ed). Folate in Health and Disease, 1st edn. NY: Marcel Dekker Inc., 1995,237-285.
29. Scientific Advisory Committee on Nutrition. Folic acid and colorectal cancer risk: Review of recommendation for mandatory folic acid fortification. 2009 (http://www.sacn.gov.uk/pdfs/summary-of-sacn-report-to-cmo-19-october-2009. pdf).
30. Sillender M, Pring DW. How effective was the Health Education Authority's folic acid campaign. J Obstet Gynaecol 2000;20:271-276. (Pubitemid 30333004)
31. Stockley L, Lund V. Folic acid supplement uptake, particularly in low-income and young women: A series of systematic reviews to inform public health policy in the UK. Public Health Nutr 2008; 11:807-821. (Pubitemid 351919756)
32. Van Beynum IM, Kapusta L, Bakker MK, den Heijer M, Blom HJ, de Walle HEK. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: A registry-based case-control study in the northern Netherlands. Eur Heart J 2010; 31:464-471.
33. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL, Ueland PM. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: The Hordaland Homocysteine Study. Am J Clin Nutr 2000;71:962-968. (Pubitemid 30176580)
34. Whiteman D, Murphy M, Hey K, O'Donnell M, Goldacre M. Reproductive factors, subfertility, and risk of neural tube defects; a case control study based on the Oxford Record Linkage Study Register. Am J Epidemiol 2000;152:823-828.